当前位置：药药网 / 数据中心 / PubMed 中的摘要说明，变体和药物之间的可能关系
利伐沙班
基因身份证
PA27114,PA131,PA134962723
基因符号
CYP3A,ZSCAN25,CYP3A5
文献标题
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
杂志
Pharmacogenomics and Personalized Medicine
句子
None of the markers under study ( CYP3A5*3 rs776746, CYP2C19*2 rs4244285, *17 rs12248560, ABCB1 3435 C>T, ABCB1 rs4148738 ) has proven to affect rivaroxaban equilibrium concentration in blood plasma among patients with atrial fibrillation and acute coronary syndrome.